Drugs that contain Aspirin; Dipyridamole
1. Aggrenox patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6015577 | BOEHRINGER INGELHEIM | Pharmaceutical compositions containing dipyridamole or mopidamol and acetylsalicylic acid or the physiologically acceptable salts thereof, processes for preparing them and their use in treating clot formation |
Jan, 2017
(7 years ago) | |
Market Authorisation Date: 22 November, 1999
Treatment: To reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
How can I launch a generic of AGGRENOX before it's drug patent expiration?
More Information on Dosage
AGGRENOX family patents
